Home
Scholarly Works
A biomarker-directed, multi-center phase II/III...
Conference

A biomarker-directed, multi-center phase II/III study of ctDNA molecular response adaptive immuno-chemotherapy in patients with non-small cell lung cancer

Authors

Anagnostou V; Moore S; Ho C; Nicholas GA; Juergens RA; Sacher AG; Fung AS; Wheatley-Price P; Laurie S; Levy BP

Volume

42

Publisher

LIPPINCOTT WILLIAMS & WILKINS

Publication Date

June 1, 2024

Name of conference

Special Clinical Science Symposia

Conference place

ELECTR NETWORK

Conference start date

May 29, 2024

Conference end date

May 29, 2024

Conference proceedings

JOURNAL OF CLINICAL ONCOLOGY

Issue

16

ISSN

0732-183X

Labels

Fields of Research (FoR)

Contact the Experts team